Vascular Endothelial Growth Factor A

CHICAGO — Anti-VEGF monotherapy for treatment of retinopathy of prematurity was more expensive than anti-VEGF therapy combined with panretinal photocoagulation, according to a speaker here, but both modalities exhibited positive outcomes at the final examination.

Consensus molecular subtype classification demonstrated potential clinical utility as an independent prognostic factor for patients with metastatic colorectal cancer who receive first-line therapy, according to results of a prospective phase 3 trial published in Journal of Clinical Oncology.